Literature DB >> 18204478

Effect of peripheral obestatin on food intake and gastric emptying in ghrelin-knockout mice.

I Depoortere1, T Thijs, D Moechars, B De Smet, L Ver Donck, T L Peeters.   

Abstract

BACKGROUND AND
PURPOSE: The finding that obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's stimulatory effect on food intake and gastric emptying has been questioned. The effect of obestatin has been mostly investigated in fasted rodents, a condition associated with high blood levels of ghrelin which may mask the effect of obestatin. We therefore investigated the effect of obestatin on food intake, gastric emptying and gastric contractility in ghrelin knockout mice. EXPERIMENTAL APPROACH: The effect of obestatin on 6-h cumulative food intake was studied in fasted wildtype (ghrelin+/+) and ghrelin knockout (ghrelin-/-) mice. In both genotypes, the effect of obestatin and/or ghrelin was studied in vivo on gastric emptying measured with the (14)C-octanoic acid breath test and in vitro on neural responses elicited by electrical field stimulation (EFS) of fundic smooth muscle strips. KEY
RESULTS: Administration of obestatin did not influence fasting-induced hyperphagia or gastric emptying in both genotypes. Injection of ghrelin accelerated gastric emptying in ghrelin+/+ and ghrelin-/- mice but the effect was not reversed by co-injection with obestatin. In fundic strips from ghrelin+/+ and ghrelin-/- mice, ghrelin increased EFS-induced contractions, but obestatin was without effect. However, co-administration with obestatin tended to reduce the excitatory effect of ghrelin in both genotypes. CONCLUSIONS AND IMPLICATIONS: In ghrelin-/- mice, obestatin failed to affect food intake and gastric motility. These results suggest that endogenous ghrelin does not mask the effect of obestatin and confirm that obestatin administered peripherally is not a major regulator of satiety signalling or gut motility.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18204478      PMCID: PMC2437905          DOI: 10.1038/sj.bjp.0707683

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  41 in total

1.  Normal food intake and body weight in mice lacking the G protein-coupled receptor GPR39.

Authors:  Frédéric Tremblay; Mylène Perreault; Lori D Klaman; James F Tobin; Erica Smith; Ruth E Gimeno
Journal:  Endocrinology       Date:  2006-11-09       Impact factor: 4.736

2.  Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin.

Authors:  A Asakawa; A Inui; T Kaga; H Yuzuriha; T Nagata; N Ueno; S Makino; M Fujimiya; A Niijima; M A Fujino; M Kasuga
Journal:  Gastroenterology       Date:  2001-02       Impact factor: 22.682

3.  Ghrelin induces adiposity in rodents.

Authors:  M Tschöp; D L Smiley; M L Heiman
Journal:  Nature       Date:  2000-10-19       Impact factor: 49.962

4.  A role for ghrelin in the central regulation of feeding.

Authors:  M Nakazato; N Murakami; Y Date; M Kojima; H Matsuo; K Kangawa; S Matsukura
Journal:  Nature       Date:  2001-01-11       Impact factor: 49.962

5.  Obestatin-mediated proliferation of human retinal pigment epithelial cells: regulatory mechanisms.

Authors:  Jesus P Camiña; Jacobo F Campos; J Eduardo Caminos; Carlos Dieguez; Felipe F Casanueva
Journal:  J Cell Physiol       Date:  2007-04       Impact factor: 6.384

6.  The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion.

Authors:  A M Wren; C J Small; H L Ward; K G Murphy; C L Dakin; S Taheri; A R Kennedy; G H Roberts; D G Morgan; M A Ghatei; S R Bloom
Journal:  Endocrinology       Date:  2000-11       Impact factor: 4.736

7.  Ghrelin is a growth-hormone-releasing acylated peptide from stomach.

Authors:  M Kojima; H Hosoda; Y Date; M Nakazato; H Matsuo; K Kangawa
Journal:  Nature       Date:  1999-12-09       Impact factor: 49.962

8.  Gut hormone PYY(3-36) physiologically inhibits food intake.

Authors:  Rachel L Batterham; Michael A Cowley; Caroline J Small; Herbert Herzog; Mark A Cohen; Catherine L Dakin; Alison M Wren; Audrey E Brynes; Malcolm J Low; Mohammad A Ghatei; Roger D Cone; Stephen R Bloom
Journal:  Nature       Date:  2002-08-08       Impact factor: 49.962

9.  Characterisation of proghrelin peptides in mammalian tissue and plasma.

Authors:  Angela S Bang; Steven G Soule; Tim G Yandle; A Mark Richards; Chris J Pemberton
Journal:  J Endocrinol       Date:  2007-02       Impact factor: 4.286

10.  Plasma obestatin levels are lower in obese and post-gastrectomy subjects, but do not change in response to a meal.

Authors:  M S B Huda; B H Durham; S P Wong; D Deepak; D Kerrigan; P McCulloch; L Ranganath; J Pinkney; J P H Wilding
Journal:  Int J Obes (Lond)       Date:  2007-07-31       Impact factor: 5.095

View more
  12 in total

1.  Circulating obestatin levels in normal and Type 2 diabetic subjects.

Authors:  D H St-Pierre; F Settanni; I Olivetti; E Gramaglia; M Tomelini; R Granata; F Prodam; A Benso; E Ghigo; F Broglio
Journal:  J Endocrinol Invest       Date:  2010-05-05       Impact factor: 4.256

Review 2.  Interaction between gastric and upper small intestinal hormones in the regulation of hunger and satiety: ghrelin and cholecystokinin take the central stage.

Authors:  Andreas Stengel; Yvette Taché
Journal:  Curr Protein Pept Sci       Date:  2011-06       Impact factor: 3.272

Review 3.  Biological effects of obestatin.

Authors:  Jiang-Bo Li; Akihiro Asakawa; Kaichun Cheng; Yingxiao Li; Huhe Chaolu; Minglun Tsai; Akio Inui
Journal:  Endocrine       Date:  2011-03-20       Impact factor: 3.633

Review 4.  Ghrelin, des-acyl ghrelin and nesfatin-1 in gastric X/A-like cells: role as regulators of food intake and body weight.

Authors:  Andreas Stengel; Miriam Goebel; Lixin Wang; Yvette Taché
Journal:  Peptides       Date:  2009-11-26       Impact factor: 3.750

Review 5.  Ghrelin and eating disorders.

Authors:  Deniz Atalayer; Charlisa Gibson; Alexandra Konopacka; Allan Geliebter
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2012-08-30       Impact factor: 5.067

6.  Obestatin induction of early-response gene expression in gastrointestinal and adipose tissues and the mediatory role of G protein-coupled receptor, GPR39.

Authors:  Jian V Zhang; Holger Jahr; Chin-Wei Luo; Cynthia Klein; Kristof Van Kolen; Luc Ver Donck; Ananya De; Esther Baart; Jing Li; Dieder Moechars; Aaron J W Hsueh
Journal:  Mol Endocrinol       Date:  2008-03-12

7.  Yin and Yang - the Gastric X/A-like Cell as Possible Dual Regulator of Food Intake.

Authors:  Andreas Stengel; Yvette Taché
Journal:  J Neurogastroenterol Motil       Date:  2012-04-09       Impact factor: 4.924

Review 8.  Adipokines in breast milk: an update.

Authors:  Gönül Çatlı; Nihal Olgaç Dündar; Bumin Nuri Dündar
Journal:  J Clin Res Pediatr Endocrinol       Date:  2014-12

9.  Assessment of Serum Concentrations of Ghrelin, Obestatin, Omentin-1, and Apelin in Children with Type 1 Diabetes.

Authors:  Agnieszka Polkowska; Izabela Szczepaniak; Artur Bossowski
Journal:  Biomed Res Int       Date:  2016-01-19       Impact factor: 3.411

Review 10.  Obestatin as a key regulator of metabolism and cardiovascular function with emerging therapeutic potential for diabetes.

Authors:  Elaine Cowan; Kerry J Burch; Brian D Green; David J Grieve
Journal:  Br J Pharmacol       Date:  2016-05-27       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.